Fred Vogt, Iovance Biotherapeutics

Being a Life Sciences Leader ›

28:41 | Feb 26th

This episode features Fred Vogt, Interim CEO at Iovance Biotherapeutics, recipient of the 2024 Patient Impact Award. In this episode, Fred shares the journey behind AMTAGVI - the first FDA approved t...Show More